No Data
No Data
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading
Trinity Biotech Acquires 12.5% Equity Stake in Novus Diagnostics
Trinity Biotech Shares Are Trading Higher After the Company Announced the Acquisition of EpiCapture. Also the Company Announced a Strategic Investment in Novus Diagnostics to Advance Development and Commercialization of Novus' Point-of-care Diagnostic...
Trinity Biotech Announces Acquisition Of Prostate Cancer Focused EpiCapture For Initial Consideration Of ~$3M, With An Additional Consideration Of $0.5M Contingent On The Achievement Of Future Milestones
Trinity Biotech Enters Oncology Space With Acquisition Of Prostate Cancer Focused EpiCapture >TRIB
Express News | Trinity Biotech Enters Oncology Space With Acquisition of Prostate Cancer Focused Epicapture